ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Early De Novo DSA with T Cell Mediated Rejection (TCMR) Is Associated with Allograft Dysfunction with Chronic Injury.

A. Cherukuri, R. Mehta, P. Sood, A. Zeevi, S. Hariharan, D. Rothstein.

UPMC, Pittsburgh.

Meeting: 2016 American Transplant Congress

Abstract number: A50

Keywords: Alloantibodies, Graft function, Rejection

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR)
  • Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

De novo anti-donor HLA specific antibody (DSA) detected post-renal transplantation is associated with adverse outcomes. However, the relationship between early de novo DSA and subsequent TCMR and its impact is unknown. In this prospective longitudinal study, DSA was measured at 0, 1, 3, 6, 9, 12 & 18m post Tx and compared to the development of TCMR on protocol (3m & 12m) and for-cause biopsies, and subsequent outcomes were assessed.

53 (18%) of 299 patients transplanted between dates 1/13 and 7/14 developed de novo DSA (IS:Thymo, MPA+TAC & rapid steroid withdrawal). In 48/53 (90%) of these patients, DSA developed early (<6m). Importantly, 20/53 (38%) patients had DSA prior to, or concomitant with, clinical/sub-clinical TCMR. Whereas 4 patients developed DSA after TCMR. 3 patients had ABMR and were excluded.

Patients with de novo DSA had significantly worse renal function at 12 and 18m vs. those without DSA. The sub-group of patients with DSA+TCMR had the worst Scr at these time points. Moreover, patients with DSA had significantly worse chronicity (IFTA & IF+i) scores- predominantly due to patients in the DSA+TCMR sub-group (Fig 1A). Patients with DSA+TCMR were significantly younger (P=0.02) and had a higher incidence of DGF (P=0.001) and both were independent risk factors (recipient age OR 0.95, P<0.05; & DGF OR 6.9, P=0.02). MFI levels for the DSA were significantly higher in the DSA+TCMR sub-group (P=0.03). 27/53 patients with de novo DSA, had PBMCs available for analysis. B cell cytokine profiles at 3m were not significantly different in patients with DSA alone vs. those without. However, patients with DSA+TCMR had a significantly lower ratio of IL-10/TNF-a expression (at or prior to the rejection episode) within T1-transitional, transitional, naïve and memory B subsets, compared to those with DSA alone or no DSA, suggesting DSA+TCMR is associated with a pro-inflammatory B cell profile (Fig 1B).

To conclude, de novo DSA with TCMR is associated with renal dysfunction and significantly worse chronic allograft injury than DSA alone. Identifying risk factors (age, DGF, B cell profile) may permit early diagnosis and treatment or prophylaxis with augmented IS.

CITATION INFORMATION: Cherukuri A, Mehta R, Sood P, Zeevi A, Hariharan S, Rothstein D. Early De Novo DSA with T Cell Mediated Rejection (TCMR) Is Associated with Allograft Dysfunction with Chronic Injury. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cherukuri A, Mehta R, Sood P, Zeevi A, Hariharan S, Rothstein D. Early De Novo DSA with T Cell Mediated Rejection (TCMR) Is Associated with Allograft Dysfunction with Chronic Injury. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/early-de-novo-dsa-with-t-cell-mediated-rejection-tcmr-is-associated-with-allograft-dysfunction-with-chronic-injury/. Accessed February 26, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.